-
COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
Mar 18, 2026, 21:38 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION ADHERENCE ON CLINICAL AND ECONOMIC OUTCOMES IN TYPE 2 DIABETES: A SCOPING REVIEW OF REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISON OF ODEVIXIBAT AND MARALIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH ALAGILLE SYNDROME (ALGS)
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF DAMOCTOCOG ALFA PEGOL VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS IN COLOMBIA, PERU AND COSTA RICA
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE UTILIZATION AND CLINICAL CHARACTERISTICS ACROSS DIABETES COMPLICATIONS SEVERITY IN MEDICARE ADVANTAGE INSURED ADULTS WITH TYPE 2 DIABETES
Mar 18, 2026, 21:38 PM -
VALIDATING PRIMARY AND SECONDARY HEALTHCARE RESOURCE USE AND COSTS ESTIMATES IN OMOP-MAPPED VS SOURCE CPRD-HES DATA IN THE UK
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVE CKD SCREENING FOR ADULTS OVER 55 ADDRESSES MEDICAID POLICY MISALIGNMENT
Mar 18, 2026, 21:38 PM -
EXPEDITED REGULATORY PATHWAYS AND REIMBURSEMENT DECISIONS FOR INNOVATIVE CANCER DRUGS IN CHINA
Mar 18, 2026, 21:38 PM -
ECONOMIC AND CLINICAL OUTCOMES OF CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES IN U.S. PEDIATRIC AND ADULT POPULATIONS: A MODELING STUDY
Mar 18, 2026, 21:38 PM -
ECOA METATEXT DEVELOPMENT: AN ESSENTIAL STEP IN MAINTAINING UX/UI ACROSS ALL LANGUAGES IN ECOA SOLUTIONS
Mar 18, 2026, 21:38 PM -
ASSESSING THE RETURN ON INVESTMENT (ROI) OF HEOR & RWE TO THE BIOPHARMACEUTICAL INDUSTRY: CASE EXAMPLE OF COMPARATIVE EFFECTIVENESS RESEARCH USING SECONDARY RWD SOURCES
Mar 18, 2026, 21:38 PM -
LINKING QUALITY AND FINANCIAL PERFORMANCE: A FIVE-YEAR LONGITUDINAL ANALYSIS OF ROI IN MEDICARE PIONEER ACOS
Mar 18, 2026, 21:38 PM -
QUALITY OF LIFE AND PRODUCTIVITY LOSS COSTS OF NERVE BLOCK WITH DEEPLY INSERTED ACUPOTOMY VERSUS NERVE BLOCK ALONE IN LUMBOSACRAL RADICULOPATHY
Mar 18, 2026, 21:38 PM -
THE ROLE OF TRANSFER LEARNING ON THE PERFORMANCE OF MACHINE LEARNING MODELS ACROSS RACIAL/ETHNIC GROUPS
Mar 18, 2026, 21:38 PM -
BUDGETARY IMPLICATIONS OF REPLACING PATENTED SEVELAMER IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASE IN MEXICO
Mar 18, 2026, 21:38 PM -
USE OF NOVEL ELEMENTS OF VALUE IN COST-EFFECTIVENESS ANALYSES: INSIGHTS FROM THE CEA REGISTRY (2016-2024)
Mar 18, 2026, 21:38 PM -
SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Mar 18, 2026, 21:38 PM -
PATIENT-CENTRIC PATHWAYS: SURVEYING TREATMENT ACCESS AND SUPPORT FOR RARE DISEASES, INCLUDING RARE CANCERS, IN EUROPE
Mar 18, 2026, 21:38 PM -
WHY CURRENT INTERTEMPORAL DISCOUNTING METHODS ARE WRONG, HOW THEY DISTORT HEALTH TECHNOLOGY ASSESSMENT, COST-EFFECTIVENESS ANALYSIS AND ESTIMATES OF THE VALUE OF A LIFE-YEAR AT FULL HEALTH, AND HOW TO FIX THE PROBLEM
Mar 18, 2026, 21:38 PM
